Literature DB >> 18715680

Synthesis, antibacterial and anticonvulsant evaluations of some cyclic enaminones.

Ivan O Edafiogho1, Oludotun A Phillips, Edet E Udo, Santosh Samuel, Beigy Rethish.   

Abstract

Several cyclic enaminone esters were synthesized, characterized, and evaluated for anticonvulsant and antibacterial activities using standardized tests. A series of enaminones were mainly phenyl analogs of anticonvulsant enaminones, while a second series comprised of compounds bearing the oxazolidinone pharmacophoric moiety found in the synthetic antibacterial linezolid. The enaminone ester bearing an unsubstituted anilino analog showed class 2 anticonvulsant activity. This represents a first report of an unsubstituted anilino enaminone with anticonvulsant activity. The enaminone esters gave interesting UV data, and four analogs displayed potent anticonvulsant activities, while another four compounds showed moderate anticonvulsant activities. Surprisingly, none of the enaminone esters had any significant antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715680     DOI: 10.1016/j.ejmech.2008.07.005

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  A substituted anilino enaminone acts as a novel positive allosteric modulator of GABA(A) receptors in the mouse brain.

Authors:  Ze-Jun Wang; Liqin Sun; Patrice L Jackson; Kenneth R Scott; Thomas Heinbockel
Journal:  J Pharmacol Exp Ther       Date:  2010-12-16       Impact factor: 4.030

Review 2.  Allosteric Modulation of GABAA Receptors by an Anilino Enaminone in an Olfactory Center of the Mouse Brain.

Authors:  Thomas Heinbockel; Ze-Jun Wang; Patrice L Jackson-Ayotunde
Journal:  Pharmaceuticals (Basel)       Date:  2014-12-17

3.  Evaluation of the antinociceptive activities of enaminone compounds on the formalin and hot plate tests in mice.

Authors:  Willias Masocha; Samuel B Kombian; Ivan O Edafiogho
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

4.  Scope and limitations of a novel synthesis of 3-arylazonicotinates.

Authors:  Omniya Sayed Zaky; Moustafa Sherief Moustafa; Maghraby Ali Selim; Awatef Mohamed El-Maghraby; Mohamed Hilmy Elnagdi
Journal:  Molecules       Date:  2012-05-18       Impact factor: 4.411

5.  Synthesis, Computational Studies and Anticonvulsant Activity of Novel Benzothiazole Coupled Sulfonamide Derivatives.

Authors:  Sukhbir L Khokra; Kanika Arora; Shah A Khan; Pawan Kaushik; Reetu Saini; Asif Husain
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.